Compound Profile: Ultima-Tesamorelin
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analogue peptide specifically engineered for laboratory research applications. This 44-amino acid synthetic peptide represents a modified version of human GHRH(1-44)amide, featuring strategic amino acid substitutions that enhance its stability and receptor binding characteristics in experimental models. Research scientists at Stroid UK Shop can examine this compound’s molecular interactions with GHRH receptors and its downstream effects on growth hormone signalling pathways.
Laboratory Applications
Research investigations with tesamorelin focus on its ability to stimulate growth hormone release through selective GHRH receptor activation. Studies have examined its mechanism of action in cellular models, demonstrating enhanced adenylyl cyclase activation and subsequent cAMP elevation in anterior pituitary cell cultures. Researchers exploring growth hormone tesamorelin acetate formulations can investigate its comparative effects against native GHRH sequences. The compound’s modified structure provides extended half-life characteristics compared to endogenous GHRH, making it valuable for sustained receptor activation studies. Laboratory investigations have also examined tesamorelin’s selectivity profile, demonstrating minimal cross-reactivity with other hypothalamic releasing hormone receptors. Researchers studying metabolic regulation pathways often evaluate tesamorelin alongside SARMs and peptides to understand growth hormone’s role in anabolic signalling cascades.
Technical Specifications
| Parameter | Specification |
|---|---|
| CAS Number | 218949-48-5 |
| Molecular Formula | C₂₂₁H₃₆₆N₇₂O₆₇S |
| Molecular Weight | 5135.77 g/mol |
| Peptide Length | 44 amino acids |
| Form | Lyophilised powder |
| Storage | -20°C (long-term), 2-8°C (reconstituted) |
| Solubility | Water, physiological buffers |
| Purity | ≥98% (HPLC verified) |
Research Compliance
Ultima-Tesamorelin 2mg is manufactured by Ultima Peptides exclusively for in-vitro laboratory research purposes. This compound is not intended for human consumption, therapeutic use, or any form of clinical application. Research institutions and qualified laboratories should maintain appropriate biosafety protocols when handling this material. All experimental procedures must comply with institutional review board guidelines and applicable research regulations. This product is restricted to qualified research professionals conducting legitimate scientific investigations into growth hormone-releasing hormone receptor biology and related endocrinological research pathways.
